Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3674192019 | Product containing precisely carbamazepine 400 milligram/1 each prolonged-release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 3674193012 | Carbamazepine 400 mg prolonged-release oral tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely carbamazepine 400 milligram/1 each prolonged-release oral tablet | Has manufactured dose form | Prolonged-release oral tablet | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely carbamazepine 400 milligram/1 each prolonged-release oral tablet | Is a | Product containing carbamazepine in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely carbamazepine 400 milligram/1 each prolonged-release oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely carbamazepine 400 milligram/1 each prolonged-release oral tablet | Has basis of strength substance | Carbamazepine | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely carbamazepine 400 milligram/1 each prolonged-release oral tablet | Has unit of presentation | Tablet | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely carbamazepine 400 milligram/1 each prolonged-release oral tablet | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely carbamazepine 400 milligram/1 each prolonged-release oral tablet | Has presentation strength numerator value | 400 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely carbamazepine 400 milligram/1 each prolonged-release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely carbamazepine 400 milligram/1 each prolonged-release oral tablet | Has precise active ingredient | Carbamazepine | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely carbamazepine 400 milligram/1 each prolonged-release oral tablet | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely carbamazepine 400 milligram/1 each prolonged-release oral tablet | Is a | Product containing only carbamazepine in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely carbamazepine 400 milligram/1 each prolonged-release oral tablet | Plays role | Anticonvulsant therapeutic role | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR